骨髓细胞白血病-1作为癌症候选预后生物标志物:系统性审查和元分析

Jianrong Wang1, Yu He1, Chao Yang1

  • 1Department of Respiratory and Critical Care Medicine, Ya'an People's Hospital, Ya'an, Sichuan, China.

概括

髓瘤细胞白血病-1 (MCL-1) 表达与癌症患者的结果有关. 高MCL-1水平与晚期癌症和某些癌症的存活率较低相关,这表明其作为预后生物标志物的潜力.